Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma

Ophthalmology

Volumn 119, Issue 1, 2012, Pages 188-192

  Shields, Carol L ^a   Kaliki, Swathi ^a   Shah, Sanket U ^a   Bianciotto, Carlos G ^a   Liu, David ^a   Jabbour, Pascal ^b   Griffin, Gregory C ^c   Shields, Jerry A ^c  

^a WILLS EYE HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTERY SPASM; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CHILD; CHOROID GYRATE ATROPHY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG EXPOSURE; DRUG WITHDRAWAL; ENUCLEATION; EYE MOVEMENT DISORDER; EYELID EDEMA; FEMALE; FOLLOW UP; HUMAN; INFANT; INTERNAL CAROTID ARTERY OCCLUSION; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEOVASCULAR GLAUCOMA; NEUTROPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PTOSIS; RETINA ARTERY OCCLUSION; RETINA DETACHMENT; RETINA NEOVASCULARIZATION; RETINOBLASTOMA; RETROSPECTIVE STUDY; STROKE; TREATMENT FAILURE; TREATMENT RESPONSE; TUMOR SEEDING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; EYE ENUCLEATION; EYE NEOPLASMS; FEMALE; HUMANS; INFANT; INFUSIONS, INTRA-ARTERIAL; MALE; MELPHALAN; NEOPLASM SEEDING; RETINAL NEOPLASMS; RETINOBLASTOMA; RETREATMENT; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME; VITREOUS BODY;

EID: 84855338045     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.06.036     Document Type: Article

References (11)

1. Shields CL, Shields JA. Intra-arterial chemoreduction for retinoblastoma: the beginning of a long journey. Clin Experiment Ophthalmol 2010;38:638-43.
2. Lin P, O'Brien JM. Frontiers in the management of retinoblastoma. Am J Ophthalmol 2009;148:192-8.
3. Shields CL, Shields JA. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol 2010:21:203-12.
4. Yamane T, Kaneko A, Mohri M. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma. Int J Clin Oncol 2004;9:69-73. (Pubitemid 38619319)
5. Abramson DH, Dunkel IJ, Brodie SE, et al. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma: initial results. Ophthalmology 2008;115:1398-404.
6. Shields CL, Bianciotto CG, Jabbour P, et al. Intra-arterial chemotherapy for retinoblastoma: report no. 1, control of retinal tumor, subretinal seeds, and vitreous seeds. Arch Ophthalmol 2011;129:1399-40.
7. Shields CL, Mashayekhi A, Au AK, et al. The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology 2006;113:2276-80. (Pubitemid 44838917)
8. Shields CL, Ramasubramanian A, Rosenwasser R, Shields JA. Superselective catheterization of the ophthalmic artery for intraarterial chemotherapy for retinoblastoma. Retina 2009;29:1207-9.
9. Abramson DH, Dunkel IJ, Brodie SE, et al. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology 2010;117:1623-9.
10. Vijayakrishnan R, Shields CL, Ramasubramanian A, et al. Irradiation toxic effects during intra-arterial chemotherapy for retinoblastoma: should we be concerned? Arch Ophthalmol 2010;128:1427-31.
11. Shields CL, Bianciotto CG, Jabbour P, et al. Intra-arterial chemotherapy for retinoblastoma: report no. 2, treatment complications. Arch Ophthalmol. 2011 Jun 13. [Epub ahead of print].